These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 37461014)

  • 1. Assessing the price levels of medical service and influential factors: evidence from China.
    Lin Y; Li L; Liu B
    BMC Public Health; 2024 Jan; 24(1):119. PubMed ID: 38191342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial and temporal differentiation and influencing factors of environmental governance performance in the Yangtze River Delta, China.
    Hou Y; Zhang K; Zhu Y; Liu W
    Sci Total Environ; 2021 Dec; 801():149699. PubMed ID: 34438147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative agglomeration level and spatial correlation of intercity manufacturing industry: An empirical study based on the cities of the Yangtze River Delta.
    Zhu K; Sun W
    PLoS One; 2023; 18(11):e0293645. PubMed ID: 37948445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-regional economic spillover and carbon productivity embodied in trade: empirical study from the Pan-Yangtze River Delta Region.
    Chen Z; Liu Y; Zhang Y; Zhong Z
    Environ Sci Pollut Res Int; 2021 Feb; 28(6):7390-7403. PubMed ID: 33029779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis on the Spatial-Temporal Evolution Characteristics and Spatial Network Structure of Tourism Eco-Efficiency in the Yangtze River Delta Urban Agglomeration.
    Sun Y; Hou G
    Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33806633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial price differences of medical services: evidence from the Yangtze River Delta in China.
    Li L; Liu B
    BMC Health Serv Res; 2023 Jul; 23(1):761. PubMed ID: 37461014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the spatial correlation and convergence of China's healthcare resources allocation: evidence from the Yangtze River Delta Region.
    Shen Y; Sun Z
    Arch Public Health; 2022 Sep; 80(1):207. PubMed ID: 36104735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Differences in Health Care Spending: A Comparative Study of Prices and Volumes Across OECD Countries.
    Lorenzoni L; Dougherty S
    Health Serv Insights; 2022; 15():11786329221109755. PubMed ID: 35783560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the Direct Settlement Policy of Trans-Provincial Outpatient Expenses Aggravate the Siphoning Effect? An Empirical Study on Yangtze River Delta, China.
    Li L; Zhou Q; Yin T; Ji Z; Zhang L
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Configuration Analysis of Influencing Factors of Technical Efficiency Based on DEA and fsQCA: Evidence from China's Medical and Health Institutions.
    Li Z; Zhang W; Kong A; Ding Z; Wei H; Guo Y
    Risk Manag Healthc Policy; 2021; 14():49-65. PubMed ID: 33447109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE PRICE AIN'T RIGHT? HOSPITAL PRICES AND HEALTH SPENDING ON THE PRIVATELY INSURED.
    Cooper Z; Craig SV; Gaynor M; Van Reenen J
    Q J Econ; 2019 Feb; 134(1):51-107. PubMed ID: 32981974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Disparity of Medical Resources and Its Effect on Mortality Rates in China.
    Chai KC; Zhang YB; Chang KC
    Front Public Health; 2020; 8():8. PubMed ID: 32117848
    [No Abstract]   [Full Text] [Related]  

  • 13. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage.
    Yip W; Fu H; Chen AT; Zhai T; Jian W; Xu R; Pan J; Hu M; Zhou Z; Chen Q; Mao W; Sun Q; Chen W
    Lancet; 2019 Sep; 394(10204):1192-1204. PubMed ID: 31571602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Health Care Spending In 2017: Growth Slows To Post-Great Recession Rates; Share Of GDP Stabilizes.
    Martin AB; Hartman M; Washington B; Catlin A
    Health Aff (Millwood); 2019 Jan; 38(1):101377hlthaff201805085. PubMed ID: 30521399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intended and unintended impacts of price changes for drugs and medical services: Evidence from China.
    Fu H; Li L; Yip W
    Soc Sci Med; 2018 Aug; 211():114-122. PubMed ID: 29935401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Price and utilisation differences for statins between four countries.
    Thai LP; Vitry AI; Moss JR
    Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):71-81. PubMed ID: 28800399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States.
    Dunn A; Grosse SD; Zuvekas SH
    Health Serv Res; 2018 Feb; 53(1):175-196. PubMed ID: 27873305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.
    Vogler S; Vitry A; Babar ZU
    Lancet Oncol; 2016 Jan; 17(1):39-47. PubMed ID: 26670089
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.